Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS) - Concepedia

Concepedia

Publication | Closed Access

Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)

53

Citations

21

References

2015

Year

Florian Posch, J. Thaler, Gerhard J. Zlabinger, Oliver Königsbrügge, Silvia Koder, Christoph Zielinski, Ingrid Pabinger, Cihan Ay

Clinical Cancer Research

Abstract

Elevated sVEGF is associated with an increased risk of VTE in patients with cancer.

References

	Year	Citations

Page 1